You are missing trading opportunities:
- Free trading apps
- Over 8,000 signals for copying
- Economic news for exploring financial markets
Registration
Log in
You agree to website policy and terms of use
If you do not have an account, please register
(UHS) - buy
Universal Health Services, issues upside guidance for FY09, sees EPS of $4.00-4.15 vs. $3.86 consensus; sees FY09 revs of $5.34 bln vs. $5.33 bln consensus.
(INT) - buy
World Fuel Services Corp, reported fourth-quarter results that beat market estimates, helped by rise in operating profits in its marine and aviation segments, and doubled its quarterly dividend.
(KSS) - short
Kohl's full-year outlook disappoints. Co issues downside guidance for Q1, sees EPS of $0.27-0.34 vs. $0.35 consensus; expects comps to be down 5-8% y/y.
(ITMN) - short
InterMune Inc, posted a wider quarterly loss on lower sales of its immune-boosting drug Actimmune, and forecast 2009 revenue well below market estimates.
(DECK) - short
Deckers Outdoor Corp, forecast 2009 profit well below market estimates. Co issues downside guidance for FY09, sees EPS of $7.27 vs. $8.05 consensus.
(WGOV) - short
Woodward Governor cuts 2009 outlook. Co lowers FY09 EPS to $1.40-1.65, vs $1.75 First Call consensus. Co also lowers FY09 revs to $1.3 bln vs $1.46 bln First Call consensus.
(HMC) - short
Honda Motor Co, to cut output at home by over 150,000 units in the year from April, bringing its Japanese production below 1 million vehicles for the first time in 14 years.
(DVA) - short
DaVita discloses that it is the subject of a number of inquiries by the federal government. Any negative findings could result in substantial financial penalties, exclusion from future participation in the Medicare programs and, criminal penalties.
(RRD) - short
Standard & Poor's Ratings Services said it is considering downgrading ratings for R.R. Donnelley & Sons Co., based on fears about the company's performance in 2009 through the economic downturn.
(HBC) - short
HSBC Holdings is going to announce plans Monday to raise at least ($17.18 billion) in fresh capital and cut its dividend, according to people familiar with the situation. Even banks that have until now remained healthy are getting hit by the global downturn.
(ACL) - buy
Alcon, Inc, the world’s leader in eye care and cataract surgery announced that the U.S. Food and Drug Administration (FDA) approved its aspheric AcrySof® IQ Toric intraocular lens (IOL)
(SYKE) - short
Sykes Enterprises 4Q profit drops 19 percent. Co issues downside guidance for Q1, sees EPS of $0.28-0.30 vs. $0.32 consensus; sees Q1 revs of $203 mln vs. $205.86 mln consensus.
(MDR) - short
McDermott 4th-qtr profit down sharply. Fourth-quarter profit fell to $43 mln, or 19 cents per share, from $160 mln, or 70 cents per share, a year before.
(GENZ) - short
Genzyme's Lumizyme faces delay after FDA rejection.
(FELE) - short
Franklin Electric posts lower-than-expected Q4 results.
(GB) - buy
Wilson Greatbatch beats by $0.13, beats on revs; guides FY09 revs in-line.
(MASI) - buy
Masimo Q4 results top estimates. Total revenue rose 20 percent to $83.1 million.
(DEO) - short
Diageo plc to cut 4% of North American workers - WSJ
(PALM) - short
Palm Inc warned of weaker-than-expected quarterly revenue due to lower demand for its older phones, a weak economy and late U.S. shipments of its Treo Pro.
(URS) - short
URS gives weak outlook. Co also issues mixed guidance for FY09, sees EPS of $2.80 vs. $2.95 consensus; sees FY09 revs of $9.5 bln vs. $10.35 bln consensus.
(WTW) - buy
Weight Watchers Q4 profit beats estimates. Co reported a fourth-quarter net income of $47.6 mln, or 62 cents per share, compared with $39.8 mln, or 50 cents per share, a year ago.
(SIGM) - buy
Sigma Designs profit tops estimates. Co Q4 adj EPS was $0.38 vs est $0.18.
(PETM) - buy
PetSmart Inc. said that its fourth-quarter profit rose to $78.4 mln, or 62 cents a share, from $75.4 mln, or 59 cents a share, in the year-ago period. Revenue rose to $1.36 bln from $1.33 bln last year.
(GYMB) - short
Gymboree gives bleak Q1 outlook. Co issues downside guidance for Q1, sees EPS of $0.18-0.25 vs. $0.76 consensus.
(FPIC) - short
FPIC Insurance reports Q4 net income per share of $0.55 vs $1.17 First Call consensus.
(COO) - buy
Cooper, fiscal 1Q profit surges. Company earned $23.9 mln, or 53 cents per share, for the quarter ended Jan. 31, compared with net income of $6.9 mln, or 15 cents per share, during the same period a year prior.
(ARST) - buy
ArcSight, Q3 profit beats Street, sees strong Q4. Co issues upside guidance for FY09, sees EPS of $0.41-0.48 vs. $0.29 consensus; sees FY09 revs of $130.9-134.9 vs. $127.34 mln consensus.
(IPI) - short
Intrepid Potash, earnings preview. IPI has a short history as the IPO was issued in April of 2008. Since then, the co missed by $0.07 in the most recent quarter (Q3). The current quarter provides more uncertainty following the reduction in sales by 50%.
(EBS) - short
Emergent BioSolutions, 4Q profit plunges. Company set its revenue outlook well below Wall Street forecasts.
(SEPR) - short
Sepracor, reports preliminary Phase II study results for SEP-225441 for the treatment of generalized anxiety disorder, did not meet its primary efficacy endpoint.
(GERN) - buy
Obama will lift stem cell research funding ban on Monday.
(STEM) - buy
Obama will lift stem cell research funding ban on Monday.
(CYTX) - buy
Obama will lift stem cell research funding ban on Monday.
(CUR) - buy
Obama will lift stem cell research funding ban on Monday.
(ASTM) - buy
Obama will lift stem cell research funding ban on Monday.
Get instant entry alerts for the Free Daily Stock Picks at Zantrio:
Stock Picks - Zantrio
Detailed performance on the Free Daily Stock Picks at Zantrio:
Stock Picks Peformance - Zantrio
Traders experienced a lack luster day in trading today, as we get off another new week in March. The deal between Merck and Schering-Plough got attention as well as, the deal with Dow Chemical and Rohm & Haas. Merger Monday as it was once known, before the economic downturn began, quite some time ago.
Free Daily Stock Picks activity and results for March 9, 2009:
GERN - position entry at 5.19, Stop Loss Level hit for a loss of 0.50 point
STEM - position entry at 2.25, 3rd Target Level hit for a gain of 0.13 points
CYTX - position entry at 3.30, Stop Loss Level hit for a loss of 0.50 points
CUR - position entry at 1.40, 3rd Target Level hit for a gain of 0.08 points
ASTM - position entry at 0.63, 3rd Target Level hit for a gain of 0.04 points
Get instant entry alerts for the Free Daily Stock Picks at Zantrio:
Stock Picks - Zantrio
Detailed performance on the Free Daily Stock Picks at Zantrio:
Stock Picks Peformance - Zantrio